1.Predictors of Colorectal Cancer Survival in Golestan, Iran: A Population-based Study.
Mohammad ARYAIE ; Gholamreza ROSHANDEL ; Shahryar SEMNANI ; Mohsen ASADI-LARI ; Mohsen AARABI ; Mohammad Ali VAKILI ; Vahideh KAZEMNEJHAD ; Seyed Mehdi SEDAGHAT ; Masoud SOLAYMANI-DODARAN
Epidemiology and Health 2013;35(1):e2013004-
OBJECTIVES: We aimed to investigate factors associated with colorectal cancer survival in Golestan, Iran. METHODS: We used a population based cancer registry to recruit study subjects. All patients registered since 2004 were contacted and data were collected using structured questionnaires and trained interviewers. All the existing evidences to determine the stage of the cancer were also collected. The time from first diagnosis to death was compared in patients according to their stage of cancer using the Kaplan-Meir method. A Cox proportional hazard model was built to examine their survival experience by taking into account other covariates. RESULTS: Out of a total of 345 subjects, 227 were traced. Median age of the subjects was 54 and more than 42% were under 50 years old. We found 132 deaths among these patients, 5 of which were non-colorectal related deaths. The median survival time for the entire cohort was 3.56 years. A borderline significant difference in survival experience was detected for ethnicity (log rank test, p=0.053). Using Cox proportional hazard modeling, only cancer stage remained significantly associated with time of death in the final model. CONCLUSIONS: Colorectal cancer occurs at a younger age among people living in Golestan province. A very young age at presentation and what appears to be a high proportion of patients presenting with late stage in this area suggest this population might benefit substantially from early diagnoses by introducing age adapted screening programs.
Cohort Studies
;
Colorectal Neoplasms
;
Humans
;
Mass Screening
;
Proportional Hazards Models
;
Surveys and Questionnaires
2.Goiter Frequency Is More Strongly Associated with Gastric Adenocarcinoma than Urine Iodine Level.
Mohammad TABAEIZADEH ; Vahid HAGHPANAH ; Abbasali KESHTKAR ; Shahryar SEMNANI ; Gholamreza ROSHANDEL ; Khadijeh ADABI ; Ramin HESHMAT ; Davood ROHANI ; Alireza KIA ; Ehsan HATAMI ; Ataollah JAHANGIRRAD ; Ramin NABIZADEH ; Bagher LARIJANI
Journal of Gastric Cancer 2013;13(2):106-110
PURPOSE: We designed our study to evaluate the hypothesis that gastric cancer is correlated with iodine deficiency or thyroid dysfunction. MATERIALS AND METHODS: We investigated the total body iodine reserve, thyroid function status and autoimmune disorder in 40 recently diagnosed gastric adenocarcinoma cases versus 80 healthy controls. The participants came from a region with high gastric cancer rate but sufficient iodine supply due to salt iodination. The investigation included urine iodine level, thyroid gland clinical and ultrasonographic examination, and thyroid function tests. RESULTS: Goiter was detected more frequently in the case group (P=0.001); such a finding, however, was not true for lower than normal urine iodine levels. The free T3 mean level was significantly lower in the case group compared to the control group (P=0.005). CONCLUSIONS: The higher prevalence of goiter rather than low levels of urinary iodine in gastric adenocarcinoma cases suggests that goiter, perhaps due to protracted but currently adjusted iodine deficiency, is more likely to be associated with gastric adenocarcinoma compared to the existing iodine deficiency itself.
Adenocarcinoma
;
Autoimmune Diseases
;
Goiter
;
Halogenation
;
Iodine
;
Porphyrins
;
Prevalence
;
Stomach Neoplasms
;
Thyroid Function Tests
;
Thyroid Gland